140 related articles for article (PubMed ID: 31288902)
1. Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients.
Tanaka K; Tachi T; Hori A; Osawa T; Nagaya K; Makino T; Inoue S; Yasuda M; Mizui T; Nakada T; Goto C; Teramachi H
Pharmazie; 2019 Jul; 74(7):439-442. PubMed ID: 31288902
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.
Dawoud DM; Smyth M; Ashe J; Strong T; Wonderling D; Hill J; Varia M; Dyer P; Bion J
Res Social Adm Pharm; 2019 Oct; 15(10):1212-1222. PubMed ID: 30389320
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
4. Hospital pharmacists' perceptions of medication counseling: A focus group study.
Chevalier BA; Watson BM; Barras MA; Cottrell WN
Res Social Adm Pharm; 2016; 12(5):756-71. PubMed ID: 26626591
[TBL] [Abstract][Full Text] [Related]
5. Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
Hirose C; Fujii H; Iihara H; Ishihara M; Nawa-Nishigaki M; Kato-Hayashi H; Ohata K; Sekiya K; Kitahora M; Matsuhashi N; Takahashi T; Okuda K; Naruse M; Ishihara T; Sugiyama T; Yoshida K; Suzuki A
Support Care Cancer; 2020 Dec; 28(12):5943-5952. PubMed ID: 32281034
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients.
Hale A; Merlo G; Nissen L; Coombes I; Graves N
BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744
[TBL] [Abstract][Full Text] [Related]
7. Billing for outpatient transplant pharmacy services.
Maldonado AQ; Seiger TC; Urann CL; McCleary JA; Goroski AL; Ojogho ON
Am J Health Syst Pharm; 2012 Jan; 69(2):144-7. PubMed ID: 22215360
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluations of clinical pharmacy services: 2006-2010.
Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.
Chinthammit C; Armstrong EP; Warholak TL
J Pharm Pract; 2012 Apr; 25(2):201-8. PubMed ID: 21987529
[TBL] [Abstract][Full Text] [Related]
10. Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer.
Tanaka K; Hori A; Tachi T; Osawa T; Nagaya K; Makino T; Inoue S; Yasuda M; Mizui T; Nakada T; Goto C; Teramachi H
J Pharm Health Care Sci; 2018; 4():9. PubMed ID: 29736254
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.
Kaya M; Nakamura K; Nagamine M; Suyama Y; Nakajo M; Uchida R; Hagikura K; Kanda A; Sugiyama K; Sugiyama R; Nakagaki S; Kimura M
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1371. PubMed ID: 33739629
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist time requirements for counseling in an outpatient pharmacy.
Oh Y; McCombs JS; Cheng RA; Johnson KA
Am J Health Syst Pharm; 2002 Dec; 59(23):2346-55. PubMed ID: 12489376
[TBL] [Abstract][Full Text] [Related]
13. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
14. Determinants affecting quality of life: implications for pharmacist counseling for patients with breast cancer in Japan.
Kawaguchi T; Iwase S; Koinuma M; Onodera Y; Takeuchi H; Umeda M; Matsunaga T; Unezaki S; Nagumo Y
Biol Pharm Bull; 2012; 35(1):59-64. PubMed ID: 22223338
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy.
Seko T; Tachi T; Hatakeyama H; Noguchi Y; Teramachi H
Int J Clin Pract; 2019 Jun; 73(6):e13349. PubMed ID: 30912226
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.
Kimura M; Go M; Iwai M; Usami E; Teramachi H; Yoshimura T
J Oncol Pharm Pract; 2017 Sep; 23(6):413-421. PubMed ID: 27328684
[TBL] [Abstract][Full Text] [Related]
17. Examining hospital pharmacists' goals for medication counseling within the communication accommodation theoretical framework.
Chevalier BA; Watson BM; Barras MA; Cottrell WN
Res Social Adm Pharm; 2016; 12(5):747-55. PubMed ID: 26626590
[TBL] [Abstract][Full Text] [Related]
18. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women.
Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL
Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease.
Altowaijri A; Phillips CJ; Fitzsimmons D
J Manag Care Pharm; 2013 Jun; 19(5):408-16. PubMed ID: 23697478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
